RE: Long Game1 May 2020 15:20
Hello Mavs,
On that point as I tend to agree with you that numerous players will need to be part of the global crisis. I was previously invested in Novacyt at levels of 2.56, 3 something and 4.57. Eventually took profits at 5, 4.86 and 4.10-4.20 ish
Still not sure if I have gotten out of Novacyt too early to be honest. My feeling is I have left this party too soon but I am weary of what will happen to this share once the mass produced rapid testers hit the market which is not long now.
Why are you so confident Novacyt can hold it's position when mass produced rapid testing hits the market? It is true Novacyt have accurate testing so that keeps them in the game. But if other equally accurate testing that is rapid testing comes, what makes you think people will want tests that take a few hours when they could get ones that take 15 mins or less? Other factors to take into account are the costs of Novacyt's tests vs competitors. And the administering effort of the test (how the sample is taken and who needs to take it) vs competitors.
What do you think the likely SP is for Novacyt this year and how confident are you in getting a good order book when rapid tests hit the scene. GDR expect to have their product on the market in 4-5 weeks and Avacta who have even more potential will be on the scene too.
It may well be that there is room for all 3 to push on but interested in people's thoughts. Right now Novacyt have early mover advantage
I have moved my focus to Avacta but I am still keeping my eye on Novacyt with a view to re-investing so am open to hear peoples views on this one in case I have missed anything. Many other investors are looking at Novacyt too and asking the same thing.
Sign In
Follow the stocks
